Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study)

Figure 1

Algorithm for the screening and follow-up of SPSW and RMW. SPSW: women aged 26–65 years attending a gynaecologic visit for spontaneous screening. RMW: recently migrated women aged 26–65 years asking for medical assessment of any health problem. HPV testing: Nucleic acid extraction from cervical samples (by NucliSENS® EasyMAG™, bioMérieux bv, France) followed by PCR amplification of a 450-base pair fragment of ORF L1 using the degenerate primer pair ELSI-f and ELSI-r.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us